Literature DB >> 9892470

In vitro human epidermal and polyethylene membrane penetration and retention of the sunscreen benzophenone-3 from a range of solvents.

R Jiang1, H A Benson, S E Cross, M S Roberts.   

Abstract

PURPOSE: To study epidermal and polyethylene membrane penetration and retention of the sunscreen benzophenone-3 (BP) from a range of single solvent vehicles and evaluate solvent effects on permeability parameters.
METHODS: The solubility of BP was measured in a number of solvents. Penetration of BP across human epidermis and high density polyethylene (HDPE) membranes was studied from 50% saturated solutions in each solvent.
RESULTS: Maximal BP fluxes from the solvents across the two membranes varied widely. Highest fluxes were observed from 90% ethanol (EtOH) for epidermis and from isopropyl myristate (IPM) and C12-15 benzoate alcohols (C12-15 BA) for HDPE membrane. Both the flux and estimated permeability coefficient and skin-vehicle partitioning of BP appeared to be related to the vehicle solubility parameter (delta(v)). The major effects of solvents on BP flux appear to be via changes in BP diffusivity through the membranes.
CONCLUSIONS: Minimal penetration of sunscreens such as BP is best achieved by choosing vehicles with a delta(v) substantially different to the solubility parameter of the membrane.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9892470     DOI: 10.1023/a:1011958006973

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  15 in total

1.  PREPARATION OF ISOLATED SHEETS OF HUMAN STRATUM CORNEUM.

Authors:  A M KLIGMAN; E CHRISTOPHERS
Journal:  Arch Dermatol       Date:  1963-12

2.  The percutaneous absorption of phenolic compounds: the effect of vehicles on the penetration of phenol.

Authors:  M S Roberts; R A Anderson
Journal:  J Pharm Pharmacol       Date:  1975-08       Impact factor: 3.765

3.  Use of solubility parameters of drug and vehicle to predict flux through skin.

Authors:  K B Sloan; S A Koch; K G Siver; F P Flowers
Journal:  J Invest Dermatol       Date:  1986-08       Impact factor: 8.551

4.  Mechanism of percutaneous absorption. IV. Penetration of nonelectrolytes (alcohols) from aqueous solutions and from pure liquids.

Authors:  R J Scheuplein; I H Blank
Journal:  J Invest Dermatol       Date:  1973-05       Impact factor: 8.551

5.  Absorption of sunscreens across human skin: an evaluation of commercial products for children and adults.

Authors:  R Jiang; M S Roberts; D M Collins; H A Benson
Journal:  Br J Clin Pharmacol       Date:  1999-10       Impact factor: 4.335

6.  Percutaneous absorption of alkanoic acids II: Application of regular solution theory.

Authors:  Z Liron; S Cohen
Journal:  J Pharm Sci       Date:  1984-04       Impact factor: 3.534

7.  Sunlight and skin cancer.

Authors:  T B Fitzpatrick; A J Sober
Journal:  N Engl J Med       Date:  1985-09-26       Impact factor: 91.245

8.  Use of theoretical partition coefficients determined from solubility parameters to predict permeability coefficients for 5-fluorouracil.

Authors:  E F Sherertz; K B Sloan; R G McTiernan
Journal:  J Invest Dermatol       Date:  1987-08       Impact factor: 8.551

9.  Increasing incidence of cutaneous melanoma in Queensland, Australia.

Authors:  R MacLennan; A C Green; G R McLeod; N G Martin
Journal:  J Natl Cancer Inst       Date:  1992-09-16       Impact factor: 13.506

10.  Skin cancer in a Queensland population.

Authors:  A Green; G Beardmore; V Hart; D Leslie; R Marks; D Staines
Journal:  J Am Acad Dermatol       Date:  1988-12       Impact factor: 11.527

View more
  2 in total

1.  Probing the effect of vehicles on topical delivery: understanding the basic relationship between solvent and solute penetration using silicone membranes.

Authors:  S E Cross; W J Pugh; J Hadgraft; M S Roberts
Journal:  Pharm Res       Date:  2001-07       Impact factor: 4.200

2.  Influence of anatomical site and topical formulation on skin penetration of sunscreens.

Authors:  Heather Ae Benson; Vikram Sarveiya; Stacey Risk; Michael S Roberts
Journal:  Ther Clin Risk Manag       Date:  2005-09       Impact factor: 2.423

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.